| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President
1 company
Durkin Bryan T is a Director at CME. Recent filings cover 0 purchases and 10 sales. Those positions are worth an estimated $11.2M at current prices.
Our model assigns Durkin Bryan T a below-average insider score of 38/100, based on 5 past trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -9.8%.
Durkin Bryan T's largest disclosed position is in CME as Director, worth about $11.2M. The recent filings there lean toward selling, a net 58,862 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | CME Cme Group Inc. | Director | Sell | 4,200 | $309.65 | $1,300,530.00 | -8.9% | -7.3% | - | |
| Aug 30, 2024 | CME Cme Group Inc. | Director | Sell | 7,593 | $214.59 | $1,629,381.87 | -12.0% | +10.3% | +23.5% | |
| Dec 11, 2023 | CME Cme Group Inc. | Director | Sell | 5,560 | $216.37 | $1,203,017.76 | -8.2% | +0.6% | +11.0% | |
| Nov 5, 2021 | CME Cme Group Inc. | Director | Sell | 10,000 | $222.07 | $2,220,652.08 | -4.6% | +10.7% | -20.5% | |
| Feb 19, 2021 | CME Cme Group Inc. | Director | Sell | 11,000 | $195.58 | $2,151,360.00 | -7.0% | +11.2% | +25.1% | |
| May 21, 2020 | CME Cme Group Inc. | Director | Sell | 9,000 | $180.11 | $1,620,990.00 | -9.9% | - | - | |
| Aug 6, 2018 | CME Cme Group Inc. | President | Sell | 11,509 | $162.01 | $1,864,573.09 | -15.1% | - | - |